Myriad Genetics
MYGN
MYGN
283 hedge funds and large institutions have $4.21B invested in Myriad Genetics in 2014 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 102 increasing their positions, 107 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
60% less call options, than puts
Call options by funds: $54.6M | Put options by funds: $137M
Holders
283
Holding in Top 10
5
Calls
$54.6M
Puts
$137M
Top Buyers
| 1 | +$81.7M | |
| 2 | +$57.3M | |
| 3 | +$51.8M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$29.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$28M |
Top Sellers
| 1 | -$74M | |
| 2 | -$69.3M | |
| 3 | -$62.1M | |
| 4 |
BTS
BB&T Securities
Richmond,
Virginia
|
-$51.2M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$48.1M |